Search

Zimmer Biomet Holdings Inc

Open

SectorHealthcare

95.81 -0.73

Overview

Share price change

24h

Current

Min

94.16

Max

96.98

Key metrics

By Trading Economics

Income

99M

239M

Sales

-157M

2.1B

P/E

Sector Avg

23.852

64.641

EPS

2.09

Dividend yield

1.05

Profit margin

11.43

Employees

17,000

EBITDA

84M

538M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+2.66% upside

Dividends

By Acuity

Dividend yield

Sector Avg

1.05%

2.31%

Next Earnings

5 Aug 2026

Next Dividend date

30 Oct 2026

Next Ex Dividend date

29 Sept 2026

Market Stats

By TradingEconomics

Market Cap

-110M

18B

Previous open

96.54

Previous close

95.81

News Sentiment

By Acuity

31%

69%

97 / 340 Healthcare

Zimmer Biomet Holdings Inc Chart

Past performance is not a reliable indicator of future results.

Related News

3 Aug 2026, 23:11 UTC

Shares of Zimmer Biomet Holdings Inc. are lower in after-market hours, showing weakness despite earlier gains and remaining above their 20-day moving average.

31 Jul 2026, 20:06 UTC

Correlated Moves

Zimmer Biomet Holdings Inc. shares are lower today, influenced by Stryker Corp's decline and broader market sentiment amid rising Treasury yields and inflation concerns.

30 Jul 2026, 19:03 UTC

Zimmer Biomet Holdings Inc shares are lower today, breaking a trend of higher closes. Broader economic indicators may contribute to market uncertainty.

29 Jul 2026, 17:46 UTC

Zimmer Biomet Holdings Inc shares are higher, continuing a positive trend since Tuesday's close. Broader market volatility is impacting sentiment amid rising oil prices.

28 Jul 2026, 20:03 UTC

News
Social Media

UBS initiated coverage on Zimmer Biomet with a Buy rating and a $115 price target, supporting shares' advance during the current trading session.

27 Jul 2026, 18:46 UTC

Correlated Moves

Zimmer Biomet Holdings Inc is advancing in Monday's session, supported by a broader rise in the medical devices sector amid declining crude oil prices.

24 Jul 2026, 19:06 UTC

Correlated Moves

Zimmer Biomet Holdings is trading higher, benefiting from a pullback in crude oil prices and positive sentiment in the health care equipment sector.

23 Jul 2026, 21:02 UTC

Zimmer Biomet Holdings Inc shares are lower in after-market hours. No specific news was identified to explain the price movement.

22 Jul 2026, 18:36 UTC

Correlated Moves

Zimmer Biomet Holdings Inc reported first-quarter adjusted EPS of $1.08, below estimates. Shares are lower today amid broader sector declines and external market pressures.

20 Jul 2026, 18:16 UTC

Zimmer Biomet Holdings Inc shares are lower amid unusual volatility and broader market concerns over rising yields and inflation fears linked to increasing oil prices.

Peer Comparison

Price change

Zimmer Biomet Holdings Inc Forecast

Price Target

By TipRanks

2.66% upside

12 Months Forecast

Average 99.56 USD  2.66%

High 115 USD

Low 83 USD

Based on 10 Wall Street analysts offering 12 month price targets forZimmer Biomet Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

10 ratings

4

Buy

6

Hold

0

Sell

Sentiment

By Acuity

97 / 340 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.
help-icon Live chat